...
首页> 外文期刊>Scientific reports. >Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications
【24h】

Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications

机译:通过碱性处理制备,详细表征空乙型肝炎病毒核心颗粒用于疫苗和基因治疗应用

获取原文
           

摘要

Hepatitis B virus (HBV) core (HBc) virus-like particles (VLPs) are one of the most powerful protein engineering tools utilised to expose immunological epitopes and/or cell-targeting signals and for the packaging of genetic material and immune stimulatory sequences. Although HBc VLPs and their numerous derivatives are produced in highly efficient bacterial and yeast expression systems, the existing purification and packaging protocols are not sufficiently optimised and standardised. Here, a simple alkaline treatment method was employed for the complete removal of internal RNA from bacteria- and yeast-produced HBc VLPs and for the conversion of these VLPs into empty particles, without any damage to the VLP structure. The empty HBc VLPs were able to effectively package the added DNA and RNA sequences. Furthermore, the alkaline hydrolysis technology appeared efficient for the purification and packaging of four different HBc variants carrying lysine residues on the HBc VLP spikes. Utilising the introduced lysine residues and the intrinsic aspartic and glutamic acid residues exposed on the tips of the HBc spikes for chemical coupling of the chosen peptide and/or nucleic acid sequences ensured a standard and easy protocol for the further development of versatile HBc VLP-based vaccine and gene therapy applications.
机译:乙型肝炎病毒(HBV)核心(HBC)样病毒样颗粒(VLP)是用于暴露免疫表位和/或细胞靶向信号的最强大的蛋白质工程工具之一,以及用于遗传物质和免疫刺激序列的包装。虽然HBC VLP及其许多衍生物在高效的细菌和酵母表达系统中产生,但现有的纯化和包装方案没有充分优化和标准化。这里,采用简单的碱性处理方法来完全从细菌和酵母产生的HBC VLP中除去内部RNA,并将这些VLP的转化为空颗粒,而不会损坏VLP结构。空HBC VLP能够有效地包装添加的DNA和RNA序列。此外,碱性水解技术出现了四种不同HBC变体的纯化和包装,其在HBC VLP峰值上携带赖氨酸残基的纯化和包装。利用所引入的赖氨酸残基和未暴露在HBC尖尖的尖端上的内在天冬氨酸和谷氨酸残基用于所选肽和/或核酸序列的化学偶联,确保了用于进一步发展的基于多功能HBC VLP的标准和简便的方案疫苗和基因治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号